268 related articles for article (PubMed ID: 24762861)
1. Role of P-glycoprotein in refractoriness of seizures to antiepileptic drugs in Lennox-Gastaut syndrome.
Kumar A; Tripathi D; Paliwal VK; Neyaz Z; Agarwal V
J Child Neurol; 2015 Feb; 30(2):223-7. PubMed ID: 24762861
[TBL] [Abstract][Full Text] [Related]
2. Use of the modified Atkins diet in Lennox Gastaut syndrome.
Sharma S; Jain P; Gulati S; Sankhyan N; Agarwala A
J Child Neurol; 2015 Apr; 30(5):576-9. PubMed ID: 24659735
[TBL] [Abstract][Full Text] [Related]
3. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
Striano P; McMurray R; Santamarina E; Falip M
Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
[TBL] [Abstract][Full Text] [Related]
5. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
[TBL] [Abstract][Full Text] [Related]
6. Ketogenic diet in patients with Lennox-Gastaut syndrome.
Caraballo RH; Fortini S; Fresler S; Armeno M; Ariela A; Cresta A; Mestre G; Escobal N
Seizure; 2014 Oct; 23(9):751-5. PubMed ID: 25011392
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
Lattanzi S; Trinka E; Russo E; Striano P; Citraro R; Silvestrini M; Brigo F
Drugs Today (Barc); 2019 Mar; 55(3):177-196. PubMed ID: 30938373
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive levetiracetam treatment in pediatric Lennox-Gastaut syndrome.
Kim HJ; Kim SH; Kang HC; Lee JS; Chung HJ; Kim HD
Pediatr Neurol; 2014 Oct; 51(4):527-31. PubMed ID: 25266616
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of add-on lacosamide in children with Lennox-Gastaut syndrome.
Grosso S; Coppola G; Cusmai R; Parisi P; Spalice A; Foligno S; Verrotti A; Balestri P
Acta Neurol Scand; 2014 Jun; 129(6):420-4. PubMed ID: 24479878
[TBL] [Abstract][Full Text] [Related]
10. Anterior corpus callosotomy in school-aged children with Lennox-Gastaut syndrome: a prospective study.
Liang S; Zhang S; Hu X; Zhang Z; Fu X; Jiang H; Xiaoman Y
Eur J Paediatr Neurol; 2014 Nov; 18(6):670-6. PubMed ID: 24912732
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Devinsky O; Patel AD; Cross JH; Villanueva V; Wirrell EC; Privitera M; Greenwood SM; Roberts C; Checketts D; VanLandingham KE; Zuberi SM;
N Engl J Med; 2018 May; 378(20):1888-1897. PubMed ID: 29768152
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Effects of Clobazam on Seizure Control and Quality of Life in Children With Lennox-Gastaut Syndrome: A Pilot Study.
Weinstock A; Agarwal N; Farooq O; Cheema Z; Hamilton D; Parrish J
J Child Neurol; 2019 Jul; 34(8):432-439. PubMed ID: 30913948
[TBL] [Abstract][Full Text] [Related]
13. Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome.
Ferrie CD
Expert Rev Neurother; 2010 Jun; 10(6):851-60. PubMed ID: 20518600
[TBL] [Abstract][Full Text] [Related]
14. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.
Press CA; Knupp KG; Chapman KE
Epilepsy Behav; 2015 Apr; 45():49-52. PubMed ID: 25845492
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
16. Sulthiame add-on therapy in children with Lennox-Gastaut syndrome: A study of 44 patients.
Caraballo RH; Flesler S; Reyes Valenzuela G; Fortini S; Chacón S; Ross L; Noli D
Seizure; 2018 Nov; 62():55-58. PubMed ID: 30286409
[TBL] [Abstract][Full Text] [Related]
17. Use of perampanel in children and adolescents with Lennox-Gastaut Syndrome.
Auvin S; Dozieres B; Ilea A; Delanoë C
Epilepsy Behav; 2017 Sep; 74():59-63. PubMed ID: 28715780
[TBL] [Abstract][Full Text] [Related]
18. Clobazam and Aggression-Related Adverse Events in Pediatric Patients With Lennox-Gastaut Syndrome.
Paolicchi JM; Ross G; Lee D; Drummond R; Isojarvi J
Pediatr Neurol; 2015 Oct; 53(4):338-42. PubMed ID: 26245776
[TBL] [Abstract][Full Text] [Related]
19. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
Summers MA; Moore JL; McAuley JW
Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394
[TBL] [Abstract][Full Text] [Related]
20. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
Nikanorova M; Brandt C; Auvin S; McMurray R
Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
